(MedPage Today) — On May 12, independent experts narrowly recommended that the FDA grant accelerated approval to Sarepta’s new gene therapy, SRP-9001 (delandistrogene moxeparvovec), for the treatment of Duchenne muscular dystrophy (DMD). These… Powered by WPeMatico
“We’re aiming to cut through the buzz around AI in healthcare to prove the promise and positive impact of this exciting technology for improving patient outcomes.” Powered by WPeMatico
In two years following 100 new-start opioid use disorder patients, Bill Farr says 94% remained in the medication-assisted treatment program – attrition rates had previously hovered around 54%. Powered by WPeMatico
New research by Wolters Kluwer shows that trust in non-traditional primary care settings continues to grow – and with rising drug costs, primary care decentralization is likely to continue. Powered by WPeMatico
New resources and proposed regulations advance Administration’s commitment to expanding health care access and fighting youth mental health crisis Powered by WPeMatico
Commissioner for Health and Food Safety Stella Kyriakides and HHS Secretary Xavier Becerra met in Brussels to launch the EU-U.S. Health Task Force. Powered by WPeMatico